Pituitary patients followed for years to uncover key outcomes
NCT ID NCT03665064
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 1500 patients with pituitary gland disorders to see how they fare over time, whether treated with medication, surgery, or just monitoring. Researchers will track tumor regrowth after surgery to find clues that predict recurrence. The goal is to learn, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict tumor regrowth after pituitary surgery and improve treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test new therapies, and results may take years to influence patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITUITARY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common drug replace surgery for pituitary tumors?
- Chemotherapy drug temozolomide under review for tough pituitary tumors
- Weekly shot could replace daily needles for kids with growth hormone deficiency
- Weekly shot could replace daily growth hormone injections for children
- Weekly shot could replace daily needles for kids with growth hormone deficiency
- New radiation approach aims to tame pituitary tumors with fewer side effects